
Beyond the needle: The future of intratumoral therapy
In this episode of Denatured, you’ll hear from Lewis Bender, CEO at Intensity Therapeutics and Paul-Peter Tak, president, CEO and board director at Candel Therapeutics. We explore how intratumoral therapies trigger systemic anti-cancer immunity from a local injection, and redefine a foundational platform in immuno-oncology.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsLewis Bender, President & CEO, Intensity TherapeuticsPaul-Peter Tak, President, CEO and Board Director, Candel TherapeuticsDisclaimer: The views expressed in this discussion by guests are their own and do...
Publisher
BioSpace
Published
November 5, 2026
Duration
21 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
BioSpace
@biospace
#needle #future #intratumoraltherapy #lifesciences
